• Home
• triple q breast
• Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

4.6 (372) · $ 18.50 · In stock

Rewiring of the 3D genome during acquisition of carboplatin

Frontiers Wnt/β-Catenin Inhibition Disrupts Carboplatin

The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers

Chromatin features constrain structural variation across evolutionary timescales. - Abstract - Europe PMC

IJMS, Free Full-Text

Examples of 3D chromatin organization in mammals. (a) Active chromatin

Whole Genome Sequencing coverage differences between the CR and PR

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer. - Abstract - Europe PMC

Rewiring of the 3D genome during acquisition of carboplatin